Doxorubicin is a chemotherapy drug widely used in ovarian, bladder, lung, thyroid and stomach cancers, but it carries a harmful side effect. The drug causes a dose-dependent heart toxicity that can lead to congestive heart failure
All news from Anaesthesiology
A new study published in the Journal of the National Cancer Institute has identified specific genes associated with increased risk for triple-negative breast cancer, providing the basis for better risk management
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form of a blood pressure disorder has added to evidence that the condition—known as preeclampsia—mainly damages the heart's ability to relax between contractions, making the organ overworked and poor at pumping blood
MRI interrater reliability is superior to that of radiographs which demonstrated a significant proportion of both false negative and false positive findings for global sacroiliitis impression among juvenile patients, according to findings published in Arthritis Research & Therapy.
A phase 3 trial evaluating lenalidomide plus rituximab for the treatment of relapsed/refractory indolent lymphoma met its primary endpoint of PFS compared with rituximab plus placebo, according to the agent’s manufacturer.
The addition of systemic therapy to involved-field radiotherapy reduced relapse and improved PFS among patients with early-stage follicular lymphoma, according to results from a randomized controlled trial.
The NPS DataHub allows forensic chemists to share data on new drug analogs, including their chemical structures and signatures, which are the keys to identifying them in the lab.
Use of the capillary action technique (nonaspiration) in fine-needle biopsy of routine thyroid nodules significantly reduces rates of nondiagnostic cytopathology compared with aspiration.
A bacteria called Enterococcus faecium is a leading cause of hospital-acquired infections, and it's been shrugging off antibiotics at an increasing rate, said senior researcher Timothy Stinear.
Low-income people with diabetes are better able to afford their medications and manage their disease in states that expanded Medicaid under the Affordable Care Act, a new study suggests.